Clinical Trial Update: Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing aflibercept with 5-FU versus FOLFOX as first-line therapy in elderly or frail elderly patients with metastatic colorectal cancer has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-FU (5-fluorouracil)
• Aflibercept (Aflibercept)

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED